WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.
"The world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe," said Dr Mariängela Simäo, WHO Assistant-Director General for Access to Health Products. "We urge manufacturers to participate in the COVAX Facility, share their knowhow and data and contribute to bringing the pandemic under control. "